🇫🇷 DINUTUXIMAB BETA in France

DINUTUXIMAB BETA (DINUTUXIMAB BETA) regulatory status in France.

Marketing authorisation

ANSM

  • Local brand name: Qarziba (previously Dinutuximab beta EUSA and Dinutuximab beta Apeiron)
  • Status: approved

DINUTUXIMAB BETA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DINUTUXIMAB BETA approved in France?

Yes. ANSM has authorised it.

Who is the marketing authorisation holder for DINUTUXIMAB BETA in France?

Marketing authorisation holder not available in our data.